Nonwovenn

Nonwovenn invested in its MediTech division by adding a new medical manufacturing suite with a Class 8 cleanroom at its headquarters in England.

Nonwovenn opened a new state-of-the-art manufacturing suite at its MediTech division headquarters in Bridgwater, UK. The facility includes a Class Eight cleanroom and supports the company's three-year growth plan targeting 14% year-on-year growth in MediTech.

Nonwovenn is upgrading an existing impregnation line and adding a second one to double production capacity as part of a £13 million transformation programme. The company is also expanding its team to support growth in respiratory protection, filtration, and acoustic products.

Nonwoven fabric-tech company Nonwovenn is investing in innovation, R&D for technical fabrics including activated carbon filtration, coalescer filtration and acoustic solutions. The investment includes upgrading an impregnation line and introducing a second line, doubling output capacity.

Nonwovenn is investing £5 million in the second phase of its transformation program to increase chemical bond production capacity, including converting existing lines and purchasing a new line, targeting the oral pouch delivery sector.

Nonwovenn announced a £5 million self-funded investment for the second phase of its expansion, focusing on increasing chemical bonding production capacity, including a new production line. This follows a £13 million first phase.

Nonwovenn invested £7 million in its Bridgwater production site over 18 months, including purchasing the freehold and installing a new chemical bonding nonwovens manufacturing line to increase capacity and access new product sectors.